The heart scan that keeps almost arriving

Quentir Medicine Monitor

Evidence-based insights for quantum medicine. Published by Quentir Systems LLC · July 13, 2026.

Magnetocardiography reads the faint magnetic field thrown off by the heart's own electrical activity, without touching the patient. It is around sixty years old, it keeps producing evidence that it sees things a standard ECG cannot, and it is still not accepted as a routine clinical tool. The gap between those last two facts is where quantum medicine actually lives, and it is worth walking slowly.

What the record actually shows

The clearest account comes from the people who have lived the technique. In a 2023 review in Frontiers in Cardiovascular Medicine, Brisinda, Fenici and Fenici, whose group has worked on magnetocardiography since the early 1980s, write that a large body of research and several clinical trials have shown it reliably supplies diagnostic electrophysiological information beyond what conventional non-invasive electrocardiographic methods provide. Because the sensors sit outside the body, the signal escapes much of the distortion that skin, fat, muscle and bone impose on readings taken at the surface.

That is a strong claim with four decades of work behind it. It is also, on its own, not enough to change a hospital's habits, and the authors are candid about why.

Why it stays out of the emergency room

The obstacle is noise. The magnetic signal of a beating heart is minuscule beside the magnetic clutter of an urban hospital, and for decades the only answer was a magnetically shielded room that a handful of institutions could afford to build and run. That constraint is loosening. In March 2019 the Ohio company Genetesis announced FDA 510(k) clearance for a cardiac imaging platform whose optically pumped magnetometers removed the liquid-helium cooling that had chained the method to specialized facilities. Take away the cooling plant and the shielded vault, and a scan that once belonged to a research center starts to fit beside a hospital bed. That is the shift worth watching, because the barrier to this technology has rarely been whether it works. It has been whether an ordinary hospital could afford to house it.

The trials that moved it toward the bedside

Hardware clearance is a starting line, not a finish. What matters next is multicenter trials that test the scan against real patients and real alternatives. Physics World reported a large multi-site United States study of unshielded magnetocardiography enrolling emergency patients with chest pain across several major centers. More recently, industry reporting described a Mayo Clinic collaboration with the startup SandboxAQ, testing room-temperature sensors the company frames as quantum sensing against angiography in a cohort of cardiac patients. Neither result settles the question, and it is important not to read a partnership or an enrollment number as a verdict. What they show is narrower and more useful: a method that has left the shielded room and is being measured against the tests a cardiologist already trusts, in the setting where it would actually be used. That is the stage at which a technology stops being promising and starts being evaluated, and it is the stage where honest reporting matters most.

The other clock in quantum medicine

The computational side of the field runs on a different schedule, and honesty about that difference is the whole point. In January 2026 Scientific Reports published a quantum denoising autoencoder for retinal fundus images, built for earlier screening of diabetic retinopathy, which its authors place among the most common causes of irreversible blindness worldwide; their starting point is that classical filters can smooth away the very microaneurysms a diagnosis leans on. Two weeks earlier, the same journal carried a large-scale statistical comparison of quantum and classical neural networks in medicine, and it is admirably plain about the ceiling: today's devices carry a minimal number of noisy qubits, which leaves known quantum algorithms for practical problems out of reach on current machines.

Read that carefully. The computational literature is not promising a faster cure next year. It is reporting careful work inside a hardware limit it states out loud, which is exactly the kind of source worth trusting.

Reading both clocks together

Hold the two side by side and the picture sharpens. Quantum sensing is at the door of the bedside, with a device clearance in hand and multicenter trials under way. Quantum computation in medicine is doing disciplined work well inside a limit its own authors describe. Chest pain drives millions of American emergency-department encounters a year, so the value of getting the first of those judgments right is considerable, and the value of not overstating the second is just as real. The question worth asking about either is the same: what does the accumulated record support today, and where does it stop? Answer that honestly, one study at a time, and the frontier stops being a slogan and becomes something you can actually plan around, whether you are a clinician, an investor, or a board member trying to tell a real signal from a hopeful one.

Primary source: Brisinda, Fenici & Fenici, Frontiers in Cardiovascular Medicine, 2023. Also drawn on: EurekAlert!, March 2019; Physics World; Scientific Reports, January 2026; and a large-scale statistical comparison in Scientific Reports. Mayo Clinic and SandboxAQ reporting via Fierce Healthcare, August 2024.

Sources

Primary source: Brisinda, Fenici & Fenici, Frontiers in Cardiovascular Medicine, 2023. Also drawn on: EurekAlert!, March 2019; Physics World; Scientific Reports, January 2026; and a large-scale statistical comparison in Scientific Reports. Mayo Clinic and SandboxAQ reporting via Fierce Healthcare, August 2024.

1. Clinical magnetocardiography: the unshielded bet, past, present, and future
2. EurekAlert, magnetocardiography research release
3. Physics World, Creavo launches largest US magnetocardiography study
4. Scientific Reports, quantum denoising for retinal imaging
5. Scientific Reports, quantum and classical neural networks in medicine

The Quantum Medicine Evidence Register

One briefing reads a single study. The Evidence Register keeps the whole field in view for you.

It is a living evidence-insights system for quantum medicine: claims tracked across regions and languages, each placed on the evidence ladder from theory to simulation to hardware experiment to real-world use, with peer-reviewed work, preprints, and company announcements weighted differently and their sources always at your elbow. Where a post like this one captures a moment, the Register keeps the picture current, updated continuously and synthesized weekly, so you can walk into a board meeting or a diligence call knowing exactly what the record supports today and where it stops.

See what the Evidence Register covers →